New drug target for remyelination in Multiple Sclerosis
Monday, July 16, 2018 - 15:50
in Health & Medicine
Remyelination, the spontaneous regeneration of the fatty insulator in the brain that keeps neurons communicating, has long been seen as crucial to the next big advance in treating multiple sclerosis (MS). However, a lack of understanding of how remyelination is stymied in the disease has hampered these efforts. Now, University at Buffalo researchers have found […]